Can You Use Retinol During Pregnancy? What Derms Say

The Bottom Line on Retinol and Pregnancy

The answer is unambiguous: stop all topical retinoids during pregnancy. This is the formal recommendation of the American Academy of Dermatology, the American College of Obstetricians and Gynecologists, the NHS, and dermatology bodies worldwide. It applies to:

• OTC retinol (all concentrations)
• Retinaldehyde
• Retinyl esters (retinyl palmitate, retinyl acetate)
• Prescription tretinoin (Retin-A)
• Prescription adapalene (Differin)
• Prescription tazarotene (Tazorac) — this one carries a formal teratogenicity contraindication
• Oral isotretinoin (Accutane) — absolute contraindication with mandatory pregnancy prevention

This is not a precautionary overreaction. The teratogenicity of retinoids is mechanistically established, and while the risk from topical OTC retinol is lower than from oral prescription retinoids, the existence of safer alternatives makes continued use during pregnancy a risk with no benefit trade-off.

Why Retinoids Are Teratogenic: The Mechanism

Retinoic acid — the biologically active form that all retinoids convert to — is a critical signaling molecule in embryonic development. It regulates the expression of Hox genes, which control the patterning of embryonic structures during the fourth week of development. In normal embryogenesis, retinoic acid concentrations are tightly regulated; disrupting this balance, particularly in the first trimester, produces a characteristic pattern of malformation.

Retinoic acid embryopathy (also called fetal retinoid syndrome) involves:

• Craniofacial abnormalities: microtia/anotia, micrognathia, cleft palate
• Central nervous system: cortical malformations
• Cardiovascular: conotruncal heart defects, aortic arch abnormalities
• Thymic aplasia or hypoplasia

This is the syndrome caused by excess retinoid signaling during organogenesis. The critical window is approximately the third to eighth week of gestation — often before a pregnancy is confirmed.

The Evidence Behind the Recommendation

Oral Isotretinoin: The Primary Evidence

The strongest evidence comes from oral isotretinoin (Accutane), used to treat severe acne. A landmark study found an unusually high relative risk of 25.6× for selected major malformations in isotretinoin-exposed pregnancies. The severity and reliability of this association established retinoic acid embryopathy as a class-defined teratogenic risk.

A 1985 New England Journal of Medicine paper (Lammer et al.) characterized the malformation pattern in isotretinoin-exposed pregnancies: 154 live births included 21 with major malformations and 12 with isolated microtia — rates far exceeding background incidence.

Topical Retinoids: Lower Absorption, Not Zero Risk

The key question is whether topical retinol — applied to skin, with low transdermal absorption — reaches the developing fetus in sufficient concentrations to produce teratogenic effects.

The systemic absorption of topical retinol is estimated to be very low. A comprehensive review of skin care product safety in pregnancy (Murase et al., Journal of the American Academy of Dermatology, 2014; PMC3114665) synthesized the available evidence:

• Prospective cohort studies of topical tretinoin use in pregnancy have not found a statistically significant increased rate of major malformations — one study of 215 tretinoin-exposed first-trimester pregnancies showed 1.9% major malformation vs. 2.6% in controls (no significant difference).
• However, four published case reports describe birth defect patterns consistent with retinoid embryopathy following topical tretinoin use.
• Systemic absorption varies by skin condition, application site, frequency, and formulation; compromised skin barrier significantly increases absorption.

The conclusion of reviewing bodies: the risk from topical retinoids is probably low but cannot be established as zero, and because effective alternatives exist, there is no clinical rationale for continued use during pregnancy.

Topical Tretinoin vs. Topical Retinol

Prescription tretinoin is already the active form (retinoic acid) and therefore has somewhat higher bioavailability than retinol, which requires enzymatic conversion. OTC retinol's systemic exposure is lower still. But the same class-effect precaution applies across the board because:

1. The teratogenic mechanism is the same (excess retinoic acid disrupting embryonic signaling)
2. Skin absorption is not zero for any topical product
3. The teratogenic window (weeks 3–8 of gestation) often precedes confirmed pregnancy
4. Safe alternatives are available and effective

What the Medical Authorities Say

The AAD's patient-facing dermatologist-approved pregnancy skincare guidance lists topical retinoids explicitly under ingredients to avoid during pregnancy.

What to Use Instead: Pregnancy-Safe Alternatives

Effective skincare during pregnancy is possible without retinoids. The following ingredients have acceptable safety profiles and dermatologist support:

For Anti-Aging and Skin Texture

Bakuchiol A meroterpene phenol that produces retinol-like gene expression changes — upregulating collagen types I, III, and IV — without being a retinoid. The 2019 British Journal of Dermatology RCT found bakuchiol 0.5% equivalent to retinol 0.5% for photoaging improvement over 12 weeks, with better tolerability. It is not a retinoid and does not share the retinoid teratogenicity mechanism. No dedicated pregnancy safety RCT exists for bakuchiol, but the pharmacological profile is reassuring. Discuss with your obstetrician. Full comparison at bakuchiol vs. retinol.

Vitamin C (L-ascorbic acid) Antioxidant with collagen-stimulating properties and established safety in pregnancy. Vitamin C serums (10%–20%) address brightness and texture during pregnancy without retinoid-associated risk.

Azelaic Acid Classified as FDA Pregnancy Category B (no evidence of fetal harm in animal studies; adequate controlled studies in pregnant women are lacking but the evidence is more reassuring than for retinoids). Effective for acne, mild hyperpigmentation, and rosacea. Available in 10%–20% formulations. ACOG supports its use during pregnancy for acne treatment.

Glycolic Acid (AHA) At concentrations below 10%, glycolic acid has a reassuring safety profile in pregnancy and is endorsed by ACOG for acne treatment. Supports cell turnover and texture without the retinoid mechanism.

Hyaluronic Acid, Niacinamide, Ceramides All well-tolerated and appropriate for pregnancy. Niacinamide (5%–10%) addresses pigmentation, pores, and barrier function without systemic risk concerns.

For Pregnancy Acne

Always confirm any active skincare ingredient with your obstetrician or dermatologist during pregnancy. This page provides information, not personalized medical advice.

When Can You Restart Retinol?

Most dermatologists and the AAD recommend waiting until after pregnancy and breastfeeding are complete before resuming retinoids, because:

1. Retinoic acid is fat-soluble and can be present in breast milk
2. The developmental sensitivity of a nursing infant to retinoid exposure is not adequately characterized
3. Safe alternatives for the breastfeeding period exist (the same list as for pregnancy)

If you are not breastfeeding, discuss restart timing with your obstetrician and dermatologist. There is no absolute minimum waiting period after delivery if breastfeeding is not occurring and your doctor approves.

A Note on Skincare Products During Pregnancy Generally

Pregnancy changes skin in multiple ways — melasma (pregnancy mask), acne, stretch marks, dry skin, and increased sensitivity are all common. A good pregnancy skincare routine is achievable without retinoids:

• Morning: gentle cleanser, vitamin C serum, niacinamide moisturizer, SPF 30+
• Evening: gentle cleanser, azelaic acid or bakuchiol, ceramide moisturizer

Sun protection is especially important during pregnancy because hormonal changes make skin more prone to hyperpigmentation (melasma). SPF 30+ broad-spectrum daily is strongly recommended throughout pregnancy.

Frequently Encountered Questions

"I used retinol before I knew I was pregnant — what do I do?" Stop immediately and contact your obstetrician. The risk from brief low-concentration topical retinol exposure is probably low, but your doctor needs to know about all exposures during the first trimester so they can provide appropriate monitoring and reassurance. This is not a reason to panic — it is a reason to have a conversation with your doctor.

"My skincare has retinyl palmitate — is that included?" Retinyl esters (retinyl palmitate, retinyl acetate, retinyl propionate) are the weakest retinoids and require multiple enzymatic conversion steps to become active. The precautionary recommendation is to avoid all retinoids during pregnancy, which includes retinyl esters. However, the practical risk from a small amount of retinyl palmitate in a sunscreen or moisturizer is likely to be very low. Discuss your specific products with your obstetrician.

"What about retinol eye creams?" The periorbital skin is thinner and absorption is relatively higher. Standard precautionary advice applies: stop retinol-containing eye creams during pregnancy along with all other retinoid products.